About i-sep
i-sep is a company based in Nantes (France) founded in 2015 by Sylvain Picot.. i-sep has raised $3.61 million across 2 funding rounds from investors including GO CAPITAL. i-sep offers products and services including same™ system and IOCS Technology. i-sep operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Scinovia and Haermonics, among others.
- Headquarter Nantes, France
- Founders Sylvain Picot
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.61 M (USD)
in 2 rounds
-
Latest Funding Round
$2.73 M (USD), Series A
Sep 30, 2019
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of i-sep
i-sep offers a comprehensive portfolio of products and services, including same™ system and IOCS Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for recovering red blood cells and platelets in surgeries.
System that enables intraoperative cell salvage for patient safety.
Unlock access to complete
Unlock access to complete
Funding Insights of i-sep
i-sep has successfully raised a total of $3.61M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.73 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $2.7M
-
First Round
First Round
(02 Nov 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Series A - i-sep | Valuation | GO CAPITAL |
|
| Nov, 2015 | Amount | Seed - i-sep | Valuation | GO CAPITAL |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in i-sep
i-sep has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GO CAPITAL. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by i-sep
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - i-sep
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
I-Sep Comparisons
Competitors of i-sep
i-sep operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Scinovia and Haermonics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hematology products and solutions are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
|
| domain | founded_year | HQ Location |
Intraoperative autotransfusion devices are developed and provided.
|
|
| domain | founded_year | HQ Location |
Augmented-reality surgical cameras for blood flow visualization are developed.
|
|
| domain | founded_year | HQ Location |
Postoperative pericardial drainage and flushing system is developed.
|
|
| domain | founded_year | HQ Location |
Develops medical devices for intraoperative blood recovery and conservation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about i-sep
When was i-sep founded?
i-sep was founded in 2015.
Where is i-sep located?
i-sep is headquartered in Nantes, France. It is registered at Nantes, Pays De La Loire, France.
Who is the current CEO of i-sep?
Sylvain Picot is the current CEO of i-sep. They have also founded this company.
Is i-sep a funded company?
i-sep is a funded company, having raised a total of $3.61M across 2 funding rounds to date. The company's 1st funding round was a Seed of $880.1K, raised on Nov 02, 2015.
What does i-sep do?
i-Sep develops advanced cell salvage solutions. Intraoperative blood salvage, also known as autologous blood transfusion or cell salvage, is a medical procedure involving recovering blood lost during surgery and re-infusing it into the patient. It is a form of autotransfusion. These are used frequently in cardiothoracic and vascular surgery, in which blood usage has traditionally been high. With a greater effort to avoid adverse events due totransfusion there has also been an emphasis on blood conservation.
Who are the top competitors of i-sep?
i-sep's top competitors include Haemonetics, VISIE and Sisu Global Health.
What products or services does i-sep offer?
i-sep offers same™ system and IOCS Technology.
Who are i-sep's investors?
i-sep has 1 investor. Key investors include GO CAPITAL.